238 related articles for article (PubMed ID: 31111533)
1. Significance of pancreatic calcification on preoperative computed tomography of intraductal papillary mucinous neoplasms.
Tsujimae M; Masuda A; Shiomi H; Toyama H; Sofue K; Ueshima E; Yamakawa K; Ashina S; Yamada Y; Tanaka T; Tanaka S; Nakano R; Sato Y; Ikegawa T; Kurosawa M; Fujigaki S; Kobayashi T; Sakai A; Kutsumi H; Zen Y; Itoh T; Fukumoto T; Kodama Y
J Gastroenterol Hepatol; 2019 Sep; 34(9):1648-1655. PubMed ID: 31111533
[TBL] [Abstract][Full Text] [Related]
2. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
[TBL] [Abstract][Full Text] [Related]
3. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
4. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
[TBL] [Abstract][Full Text] [Related]
6. Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis.
Attiyeh MA; Chakraborty J; Gazit L; Langdon-Embry L; Gonen M; Balachandran VP; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Allen PJ; Do RK; Simpson AL
HPB (Oxford); 2019 Feb; 21(2):212-218. PubMed ID: 30097414
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of low serum pancreatic enzymes in invasive intraductal papillary mucinous neoplasms.
Yagi Y; Masuda A; Zen Y; Takenaka M; Toyama H; Sofue K; Shiomi H; Kobayashi T; Nakagawa T; Yamanaka K; Hoshi N; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T
Pancreatology; 2016; 16(5):893-9. PubMed ID: 27394653
[TBL] [Abstract][Full Text] [Related]
8. The role of pancreatic juice cytology in the diagnosis of pancreatic intraductal papillary mucinous neoplasm.
Tag-Adeen M; Ozawa E; Ogihara K; Iwatsu S; Akazawa Y; Ohnita K; Adachi T; Sumida Y; Nakao K
Rev Esp Enferm Dig; 2018 Dec; 110(12):775-781. PubMed ID: 30168338
[TBL] [Abstract][Full Text] [Related]
9. Chronic Pancreatitis Finding by Endoscopic Ultrasonography in the Pancreatic Parenchyma of Intraductal Papillary Mucinous Neoplasms Is Associated with Invasive Intraductal Papillary Mucinous Carcinoma.
Takenaka M; Masuda A; Shiomi H; Yagi Y; Zen Y; Sakai A; Kobayashi T; Arisaka Y; Okabe Y; Kutsumi H; Toyama H; Fukumoto T; Ku Y; Kudo M; Azuma T
Oncology; 2017; 93 Suppl 1():61-68. PubMed ID: 29258092
[TBL] [Abstract][Full Text] [Related]
10. Malignant potential and specific characteristics of pure main duct type intraductal papillary mucinous neoplasm.
Fujita Y; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Ueno M; Hayami S; Kobayashi R; Yanagisawa A; Yamaue H
Eur J Surg Oncol; 2022 May; 48(5):1054-1061. PubMed ID: 34933794
[TBL] [Abstract][Full Text] [Related]
11. Intraductal papillary mucinous neoplasms with associated invasive carcinoma of the pancreas: imaging findings and diagnostic performance of MDCT for prediction of prognostic factors.
Kim JH; Eun HW; Kim KW; Lee JY; Lee JM; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):565-72. PubMed ID: 23971447
[TBL] [Abstract][Full Text] [Related]
12. Tumor-to-blood pool ratio of 18F-fluorodeoxyglucose-positron emission tomography's standardized uptake value as a useful parameter indicating malignant transformation in pancreatic branch-duct intraductal papillary mucinous neoplasm compared to the international Fukuoka guidelines: a retrospective cohort study from surgical resections.
Suto H; Ando Y; Matsukawa H; Oshima M; Kamada H; Kobara H; Masaki T; Tanaka K; Norikane T; Nishiyama Y; Hirao T; Kumamoto K; Okano K
HPB (Oxford); 2024 Feb; 26(2):291-298. PubMed ID: 37951806
[TBL] [Abstract][Full Text] [Related]
13. Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas.
Hirono S; Yamaue H
Surg Today; 2020 Jan; 50(1):50-55. PubMed ID: 31807871
[TBL] [Abstract][Full Text] [Related]
14. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
15. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic fat content may increase the risk of imaging progression in low-risk branch duct intraductal papillary mucinous neoplasm.
Kashiwagi K; Minami K; Seino T; Hirata K; Iwasaki E; Inoue N; Iwao Y; Kanai T
J Dig Dis; 2019 Oct; 20(10):557-562. PubMed ID: 31322828
[TBL] [Abstract][Full Text] [Related]
17. The malignant potential of pancreatic intraductal papillary mucinous neoplasm is reflected in expression levels of fucosylated glycans in α
Kubo N; Yazawa S; Yokobori T; Sano R; Eguchi H; Kobayashi S; Akita H; Mitsufuji S; Yamashita YI; Nakao Y; Fujii T; Okumura T; Shibuya K; Hoshino Y; Yamada S; Hayashi M; Shimokawa M; Shirabe K
J Hepatobiliary Pancreat Sci; 2023 Apr; 30(4):503-513. PubMed ID: 35776060
[TBL] [Abstract][Full Text] [Related]
18. The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms.
Arima K; Okabe H; Hashimoto D; Chikamoto A; Kuroki H; Taki K; Kaida T; Higashi T; Nitta H; Komohara Y; Beppu T; Takeya M; Baba H
J Gastrointest Surg; 2015 Dec; 19(12):2171-7. PubMed ID: 26443528
[TBL] [Abstract][Full Text] [Related]
19. Calcifying obstructive pancreatitis: a study of intraductal papillary mucinous neoplasm associated with pancreatic calcification.
Zapiach M; Yadav D; Smyrk TC; Fletcher JG; Pearson RK; Clain JE; Farnell MB; Chari ST
Clin Gastroenterol Hepatol; 2004 Jan; 2(1):57-63. PubMed ID: 15017633
[TBL] [Abstract][Full Text] [Related]
20. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Correlation of Helical Computed Tomography (CT) Features With Pathologic Findings.
Xu W; Liu X; Zhang J; Yang L
Acad Radiol; 2017 May; 24(5):609-614. PubMed ID: 28153575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
